http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102971313-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
filingDate 2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2584a92d398cd910920e8a4b13662caa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63c399a88187a8709ec85bcb2c517553
publicationDate 2013-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102971313-A
titleOfInvention Novel glucokinase activators and methods of use thereof
abstract The present invention provides a compound or a pharmaceutically acceptable salt thereof, which is an activator of glucokinase and is therefore useful in the treatment of diabetes and related diseases, the compound has the following structure, wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , Y and X are as defined in this application. The present invention also provides methods for treating diabetes and related diseases with the above compounds.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109715637-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023138637-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109715637-A
priorityDate 2010-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135584220
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416224055
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23160273
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424466225
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23160372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424369724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18967624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467756555
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421759037
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424463211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466489724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135489577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424465102

Total number of triples: 51.